La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Mesh.i » - entrée « Huntington Disease »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Huntingtin Protein < Huntington Disease < Hydrazines  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]
Ident.Authors (with country if any)Title
000204 (2001) M. Giménez Y Ribotta [France]Gene therapy strategies in neurodegenerative diseases.
000206 (2001) M. Peschanski[10 years of substitution therapy for neurodegenerative diseases using fetal neuron grafts: a positive outcome but with questions for the future].
000455 (2004) M. Desmurget [France] ; V. Gaveau ; P. Vindras ; R S Turner ; E. Broussolle ; S. ThoboisOn-line motor control in patients with Parkinson's disease.
000535 (2005) Guylaine Hoffner [France] ; Philippe DjianTransglutaminase and diseases of the central nervous system.
000545 (2006) Arnaud Delval [France] ; Pierre Krystkowiak ; Jean-Louis Blatt ; Etienne Labyt ; Kathy Dujardin ; Alain Destée [France] ; Philippe Derambure ; Luc Defebvre [France]Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical study.
000591 (1991) G K Lloyd [France] ; A. Lowenthal ; F. Javoy-Agid ; J. ConstantidinisGABAA receptor complex function in frontal cortex membranes from control and neurological patients.
000819 (1991) B. Pillon [France] ; B. Dubois ; A. Ploska ; Yves Agid [France]Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
000832 (1991) B. Pillon [France] ; B. Dubois ; Yves Agid [France]Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
000846 (2008) Giovanni Stevanin [France] ; Alexis BriceSpinocerebellar ataxia 17 (SCA17) and Huntington's disease-like 4 (HDL4).
000A42 (2010) Paolo Gubellini [France] ; Barbara Picconi ; Massimiliano Di Filippo ; Paolo CalabresiDownstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: from experimental models to neurodegenerative diseases.
000A69 (1990) F. Thibaut [France] ; E C Hirsch ; R. Raisman ; F. Javoy-Agid ; Yves Agid [France]Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study.
000F79 (2012) L. Lescaudron [France] ; P. Naveilhan ; I. NeveuThe use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
001440 (2014) Anthony H V. Schapira [Royaume-Uni] ; C Warren Olanow [États-Unis] ; J Timothy Greenamyre [États-Unis] ; Erwan Bezard [France]Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.
001464 (2014) C. Corbier [France] ; M. El BadaouiARMA modelling and nonparametric probability density function of gait signal using L2-L1 estimator in patients with neurodegenerative disease.
001514 (2014) Mauricio G. Martín [Argentine] ; Frank Pfrieger [France] ; Carlos G. Dotti [Espagne]Cholesterol in brain disease: sometimes determinant and frequently implicated
001515 (1989) E C Hirsch [France] ; A M Graybiel ; L B Hersh ; C. Duyckaerts ; Yves Agid [France]Striosomes and extrastriosomal matrix contain different amounts of immunoreactive choline acetyltransferase in the human striatum.
001585 (2014) P. Remy [France]Biotherapies in brain diseases: for who, when and how?
001640 (2015) E. Baratin [France] ; L. Sugavaneswaran [Canada] ; K. Umapathy [Canada] ; C. Ioana [France] ; S. Krishnan [Canada]Wavelet-based characterization of gait signal for neurological abnormalities.
001752 (2015) Ling Shan [États-Unis] ; Yves Dauvilliers [France] ; Jerome M. Siegel [États-Unis]Interactions of the histamine and hypocretin systems in CNS disorders.
001C30 (1987) A M Bonnet [France] ; G. Tell ; P J Schechter ; J. Grove ; M H Saint-Hilaire ; Y. De Smet ; Yves Agid [France]Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
001D07 (1994) F. Pasquier [France] ; M. Van Der Linden ; V. Lefebvre ; C. Lefebvre ; R. Bruyer ; H. PetitMotor memory and the preselection effect in Huntington's and Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Huntington Disease" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Huntington Disease" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Huntington Disease
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024